Elevance earnings are scheduled for release before the market opens on October 21, 2026, with analysts expecting declines in both third-quarter earnings per share and revenue. As of October 20, those figures remain forecasts rather than reported results.
Key Takeaways
- Analysts expect earnings per share of $4.69, down 22.2% year over year.
- Revenue is forecast at $49.16 billion, a decline of 1.9%.
- Management will discuss the results and its outlook on October 21.
Table of Contents
- Elevance earnings expectations point to a steeper profit decline
- Insurance operations and Carelon frame the business
- Conclusion
Elevance earnings expectations point to a steeper profit decline
The expected decline in earnings per share is substantially larger than the projected revenue decrease. The release will establish whether that gap materialized; the estimates alone do not identify the reasons for it.
Elevance Health’s third-quarter results timetable sets publication for 6:00 a.m. Eastern Daylight Time on October 21, followed by a management conference call at 8:30 a.m. The company announced the schedule on October 5.
The analyst forecasts are not management guidance. The results and accompanying outlook discussion will provide separate benchmarks for assessing the quarter’s performance and management’s expectations.
| Item | Details |
|---|---|
| Results publication | October 21, 2026, at 6:00 a.m. EDT |
| Management conference call | October 21, 2026, at 8:30 a.m. EDT |
| Dividend yield | 1.72% in the October 20 pre-earnings snapshot |
| Three-year dividend growth | 10.1% compound annual growth rate |
Insurance operations and Carelon frame the business
Elevance Health, formerly known as Anthem before its 2022 rebranding, operates Anthem-branded health plans in 14 states. Its insurance businesses span commercial employer coverage, individual exchanges, Medicare Advantage and Medicaid.
The company also operates Carelon, which provides healthcare services including pharmacy benefit management and behavioral health. That gives Elevance activities beyond health insurance alone, making the performance of its service operations relevant alongside its insurance results.
Ahead of the release, Elevance’s dividend metrics showed a payout ratio of 30% and continued growth over the preceding three years. Those measures describe its existing distribution profile, but do not guarantee future payments or establish how third-quarter earnings performed.
Conclusion
The next scheduled milestones are the October 21 results release and management call, which will allow investors to compare actual performance with forecasts and hear the company’s outlook.
Read More News
Disclaimer
This FinanceVelix article provides general information, not personalized financial, investment, legal, or tax advice. Market prices, interest rates and economic conditions can change; investments carry a risk of loss. Facts reflect the material available when published and may change. Check important information independently and consult a qualified professional when needed. Mentioning an asset, company, or service is not an endorsement.
